神経内分泌腫瘍治療の世界市場2019-2023...市場調査レポートについてご紹介

【英文タイトル】Global Neuroendocrine Tumors Therapeutics Market 2019-2023

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

2.1 Preface

2.2 Preface

2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: MARKET SEGMENTATION BY TYPE

Market segmentation by type

Comparison by type

Somatostatin analogs – Market size and forecast 2018-2023

Targeted therapies – Market size and forecast 2018-2023

Other therapies – Market size and forecast 2018-2023

Market opportunity by type

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America – Market size and forecast 2018-2023

Europe – Market size and forecast 2018-2023

Asia – Market size and forecast 2018-2023

ROW – Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

Overview

Landscape disruption

Competitive scenario

PART 13: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

F. Hoffmann-La Roche Ltd

Ipsen Pharma

Merck & Co., Inc

Novartis AG

Pfizer Inc.

PART 14: APPENDIX

Research methodology

List of abbreviations

PART 15: EXPLORE TECHNAVIO

Exhibit 01: Global pharmaceuticals market

Exhibit 02: Segments of global pharmaceuticals market

Exhibit 03: Market characteristics

Exhibit 04: Market segments

Exhibit 05: Market definition – Inclusions and exclusions checklist

Exhibit 06: Market size 2018

Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)

Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)

Exhibit 09: Five forces analysis 2018

Exhibit 10: Five forces analysis 2023

Exhibit 11: Bargaining power of buyers

Exhibit 12: Bargaining power of suppliers

Exhibit 13: Threat of new entrants

Exhibit 14: Threat of substitutes

Exhibit 15: Threat of rivalry

Exhibit 16: Market condition – Five forces 2018

Exhibit 17: Type – Market share 2018-2023 (%)

Exhibit 18: Comparison by type

Exhibit 19: Somatostatin analogs – Market size and forecast 2018-2023 ($ millions)

Exhibit 20: Somatostatin analogs – Year-over-year growth 2019-2023 (%)

Exhibit 21: Targeted therapies – Market size and forecast 2018-2023 ($ millions)

Exhibit 22: Targeted therapies – Year-over-year growth 2019-2023 (%)

Exhibit 23: Other therapies – Market size and forecast 2018-2023 ($ millions)

Exhibit 24: Other therapies – Year-over-year growth 2019-2023 (%)

Exhibit 25: Market opportunity by type

Exhibit 26: Customer landscape

Exhibit 27: Market share by geography 2018-2023 (%)

Exhibit 28: Geographic comparison

Exhibit 29: North America – Market size and forecast 2018-2023 ($ millions)

Exhibit 30: North America – Year-over-year growth 2019-2023 (%)

Exhibit 31: Top 3 countries in North America

Exhibit 32: Europe – Market size and forecast 2018-2023 ($ millions)

Exhibit 33: Europe – Year-over-year growth 2019-2023 (%)

Exhibit 34: Top 3 countries in Europe

Exhibit 35: Asia – Market size and forecast 2018-2023 ($ millions)

Exhibit 36: Asia – Year-over-year growth 2019-2023 (%)

Exhibit 37: Top 3 countries in Asia

Exhibit 38: ROW – Market size and forecast 2018-2023 ($ millions)

Exhibit 39: ROW – Year-over-year growth 2019-2023 (%)

Exhibit 40: Top 3 countries in ROW

Exhibit 41: Key leading countries

Exhibit 42: Market opportunity

Exhibit 43: Impact of drivers and challenges

Exhibit 44: Strategic alliances in global neuroendocrine tumors therapeutics market: Overview

Exhibit 45: Vendor landscape

Exhibit 46: Landscape disruption

Exhibit 47: Vendors covered

Exhibit 48: Vendor classification

Exhibit 49: Market positioning of vendors

Exhibit 50: F. Hoffmann-La Roche Ltd – Vendor overview

Exhibit 51: F. Hoffmann-La Roche Ltd – Business segments

Exhibit 52: F. Hoffmann-La Roche Ltd – Organizational developments

Exhibit 53: F. Hoffmann-La Roche Ltd – Geographic focus

Exhibit 54: F. Hoffmann-La Roche Ltd – Segment focus

Exhibit 55: F. Hoffmann-La Roche Ltd – Key offerings

Exhibit 56: F. Hoffmann-La Roche Ltd – Key customers

Exhibit 57: Ipsen Pharma – Vendor overview

Exhibit 58: Ipsen Pharma – Business segments

Exhibit 59: Ipsen Pharma – Organizational developments

Exhibit 60: Ipsen Pharma – Geographic focus

Exhibit 61: Ipsen Pharma – Segment focus

Exhibit 62: Ipsen Pharma – Key offerings

Exhibit 63: Ipsen Pharma – Key customers

Exhibit 64: Merck & Co., Inc – Vendor overview

Exhibit 65: Merck & Co., Inc – Business segments

Exhibit 66: Merck & Co., Inc – Organizational developments

Exhibit 67: Merck & Co., Inc – Geographic focus

Exhibit 68: Merck & Co., Inc – Segment focus

Exhibit 69: Merck & Co., Inc – Key offerings

Exhibit 70: Merck & Co., Inc – Key customers

Exhibit 71: Novartis AG – Vendor overview

Exhibit 72: Novartis AG – Business segments

Exhibit 73: Novartis AG – Organizational developments

Exhibit 74: Novartis AG – Geographic focus

Exhibit 75: Novartis AG – Segment focus

Exhibit 76: Novartis AG – Key offerings

Exhibit 77: Novartis AG – Key customers

Exhibit 78: Pfizer Inc. – Vendor overview

Exhibit 79: Pfizer Inc. – Business segments

Exhibit 80: Pfizer Inc. – Organizational developments

Exhibit 81: Pfizer Inc. – Geographic focus

Exhibit 82: Pfizer Inc. – Segment focus

Exhibit 83: Pfizer Inc. – Key offerings

Exhibit 84: Pfizer Inc. – Key customers

Exhibit 85: Validation techniques employed for market sizing


【レポート販売概要】

■ タイトル:神経内分泌腫瘍治療の世界市場2019-2023
■ 英文:Global Neuroendocrine Tumors Therapeutics Market 2019-2023
■ 発行日:2019年4月10日
■ 調査会社:Technavio
■ 商品コード:IRTNTR31154
■ 調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。